Athyrium Capital Management is a leading investment management platform dedicated to global opportunities in the healthcare sector.

View Portfolio selection arrow

2008

Founding Year

$5B+

Capital Invested

85+

Portfolio Companies

20+

Professionals

Meet Our Investment Team selection arrow

Why Choose Athyrium

 

Active advisor to fund portfolio companies
Global network of innovators, leaders and experts
Healthcare expertise developed over 18+ years of average partner investing experience
Financing solutions to achieve growth objectives
Contact Us selection arrow

Our funds have flexible investment mandates that can accommodate the objectives of portfolio companies.

Learn More selection arrow

Relationships with Industry–Leading Companies

 

Previous
Basilea Pharmaceutica

Basilea Pharmaceutica

Pharmaceutical

Calliditas Therapeutics

Calliditas Therapeutics

Pharmaceutical

Choice Health At Home

Choice Health At Home

Health Care Services

Coherus Biosciences

Coherus Biosciences

Biotechnology

Esperion Therapeutics

Esperion Therapeutics

Pharmaceutical

Unlock Health

Unlock Health

Health Care Technology

Next
View Portfolio selection arrow

Recent Investments and Press Releases

 

Doctors and financial funder shaking hands

February 6, 2025

Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics selection arrow

February 5, 2025

Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. Announce Exit from Pharmaceutics International, Inc. selection arrow

February 4, 2025

Jabil Acquires Pharmaceuticals International, Inc selection arrow

December 18, 2024

Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions selection arrow

November 6, 2024

Choice Health at Home Acquires Accentra selection arrow

October 24, 2024

Humana and Longevity Health Multi-State Agreement Expands Access to Humana Together in Health Special Needs Plans selection arrow

Read More News selection arrow